Mobility paves Samsung’s silver path
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
The World Health Organization (WHO) urged Russia to adhere to the established guidelines for its vaccine trials and development. This comes after the country announced its plan to start mass-producing its vaccine in September after the regulatory approval.
Russia averred on Monday that it aims to mass-produce the vaccine in September and produce "several million" doses per month by next year.
Russia is going forward with several vaccine prototypes. Officials claimed that the vaccine that is being developed by the Gamaleya institute in Moscow has reached the advanced stage of development and is about to pass state registration.
"We are very much counting on starting mass production in September," Industry Minister Denis Manturov said in an interview published by state news agency TASS as cited in the AFP report.
Speaking on the development in Russia, WHO highlighted that all vaccine candidates must go through the full stages of testing before they roll out the treatment.
"There are established practices and there are guidelines out," WHO spokesman Christian Lindmeier told reporters at the United Nations in Geneva.
"Any vaccine...(or medicine) for this purpose should be, of course, going through all the various trials and tests before being licensed for roll-out," he said.
.
"But between finding or having a clue of maybe having a vaccine that works, and having gone through all the stages, is a big difference," he added.
Last week, Russian Health Minister Mikhail Murashko said to media: "The vaccine against coronavirus infection, developed by the Gamaleya Institute, has completed clinical trials," as per Sputnik news report.
He also informed that the country is going to organize a mass vaccination campaign against the novel coronavirus for October.
"We plan wider vaccinations for October," Murashko was quoted as saying, Reuters reported.
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
Antrix should adopt a different tactic than merely fighting over jurisdiction: Experts
Invest in relationships, enterprise, behaviour, effort and learning
From different types of osmoses to new membranes, researchers have come up with ways of drawing water
What filters should you apply when mining for under-the-radar small-cap stocks? Read on to find more
There’s no reason to bail out of your fund as long as it’s matching the category average
Amid choppiness, the benchmark indices slipped marginally; approach the week with caution
SBI Cards (₹1,032.7): Witnesses fresh breakoutBetween September and December last year, the stock of SBI Cards ...
What makes the new crop of young Indian cricketers such game-changing winners? Over and above their talent, ...
For their dead, Parsis practise a 3,000-year-old system where corpses are excarnated in the Tower of Silence, ...
The morning she gave Peter and Neha, and their baby daughter Minty, a tour of Ambassador Apartments, Mrs ...
It’s the 111th birth anniversary of jazz musician and guitar genius Jean ‘Django’ Reinhardt. This week’s quiz ...
Digital is becoming dominant media, but are companies and their ad agencies transforming fast enough to make a ...
Slow Network, promoted by journalist-lyricist Neelesh Misra, pushes rural products and experiences
How marketers can use the traditional exchange of festive wishes meaningfully
For Fortune, a brand celebrating its 20th anniversary, it was a rude shock to become the butt of social media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor